Patents by Inventor Brian Jeffery Sparks

Brian Jeffery Sparks has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9254334
    Abstract: Disclosed are compounds, compositions and methods for systemic and local delivery of biologically active molecules.
    Type: Grant
    Filed: December 18, 2014
    Date of Patent: February 9, 2016
    Assignee: CLSN Laboratories, Inc.
    Inventors: Gregory Slobodkin, Richard Congo, Majed Matar, Jason Fewell, Khursheed Anwer, Brian Jeffery Sparks
  • Publication number: 20150099000
    Abstract: Disclosed are compounds, compositions and methods for systemic and local delivery of biologically active molecules.
    Type: Application
    Filed: December 18, 2014
    Publication date: April 9, 2015
    Applicant: CLSN Laboratories, Inc.
    Inventors: Gregory SLOBODKIN, Richard Congo, Majed Matar, Jason Fewell, Khursheed Anwer, Brian Jeffery Sparks
  • Patent number: 8932638
    Abstract: Disclosed are compounds, compositions and methods for systemic and local delivery of biologically active molecules.
    Type: Grant
    Filed: March 8, 2013
    Date of Patent: January 13, 2015
    Assignee: CLSN Laboratories, Inc.
    Inventors: Gregory Slobodkin, Richard Congo, Majed Matar, Jason Fewell, Khursheed Anwer, Brian Jeffery Sparks
  • Patent number: 8900621
    Abstract: Disclosed are compounds, compositions and methods for systemic and local delivery of biologically active molecules.
    Type: Grant
    Filed: March 8, 2013
    Date of Patent: December 2, 2014
    Assignee: CLSN Laboratories, Inc.
    Inventors: Gregory Slobodkin, Richard Congo, Majed Matar, Jason Fewell, Khursheed Anwer, Brian Jeffery Sparks
  • Publication number: 20140050775
    Abstract: Disclosed are compounds, compositions and methods for systemic and local delivery of biologically active molecules.
    Type: Application
    Filed: March 8, 2013
    Publication date: February 20, 2014
    Applicant: Egen, Inc.
    Inventors: Gregory Slobodkin, Richard Congo, Majed Matar, Jason Fewell, Khursheed Anwer, Brian Jeffery Sparks
  • Publication number: 20130251809
    Abstract: Disclosed are compounds, compositions and methods for systemic and local delivery of biologically active molecules.
    Type: Application
    Filed: March 8, 2013
    Publication date: September 26, 2013
    Applicant: Egen, Inc.
    Inventors: Gregory Slobodkin, Richard Congo, Majed Matar, Jason Fewell, Khursheed Anwer, Brian Jeffery Sparks
  • Patent number: 8460696
    Abstract: Disclosed are compounds, compositions and methods for systemic and local delivery of biologically active molecules.
    Type: Grant
    Filed: March 19, 2010
    Date of Patent: June 11, 2013
    Assignee: Egen, Inc.
    Inventors: Gregory Slobodkin, Richard Congo, Majed Matar, Jason Fewell, Khursheed Anwer, Brian Jeffery Sparks
  • Publication number: 20100260817
    Abstract: Disclosed are compounds, compositions and methods for systemic and local delivery of biologically active molecules.
    Type: Application
    Filed: March 19, 2010
    Publication date: October 14, 2010
    Inventors: Gregory Slobodkin, Richard Congo, Majed Matar, Jason Fewell, Khursheed Anwer, Brian Jeffery Sparks
  • Publication number: 20100004315
    Abstract: Disclosed is a cross-linked branched poly(alkylenimine) and compositions thereof and nucleotide molecules. Also disclosed are methods for preparing the cross-linked branched poly(alkylenimine).
    Type: Application
    Filed: March 16, 2009
    Publication date: January 7, 2010
    Inventors: Gregory Slobodkin, Majed Matar, Brian Jeffery Sparks, Jason Fewell, Khursheed Anwer
  • Publication number: 20100004313
    Abstract: Nucleotide delivery polymers, compositions, and associated methods for the enhancement of gene delivery and expression in solid tissues are provided. In one aspect, for example, a nucleotide delivery polymer may include a poloxamer backbone having a metal chelator covalently coupled to at least one terminal end of the poloxamer backbone. In another aspect, the nucleotide expression polymer has a metal chelator coupled to at least two terminal ends of the poloxamer backbone.
    Type: Application
    Filed: February 27, 2009
    Publication date: January 7, 2010
    Inventors: Gregory Slobodkin, Majed Matar, Brian Jeffery Sparks, Jason Fewell, Khursheed Anwer